Lisata Therapeutics, Inc.
NASDAQ: LSTA1 known investors
Lisata develops drug delivery platform technology and therapies for solid tumors, enabling targeted anti-cancer drug delivery and immune system activation against cancer.
Investors · 1
Competitors · 3
by search overlapAmerican Cancer Society (ACS)61 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
Cancerresearchuk59 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer Center53 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.
Companies competing with Lisata Therapeutics, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Lisata Therapeutics, Inc. do?
- Lisata develops drug delivery platform technology and therapies for solid tumors, enabling targeted anti-cancer drug delivery and immune system activation against cancer.
- Who are Lisata Therapeutics, Inc.'s investors?
- Lisata Therapeutics, Inc.'s investors include Kyoto University Innovation Capital.